Message from Maureen Graham

Diamond Pharma Services is the umbrella brand under which the group of companies are promoted. As such Diamond Pharma Services is a leading technical and scientific consulting group of companies serving the biotechnology and pharmaceutical industry.

Our emphasis is on the following areas:

Regulatory Affairs: From Product Concept to Registration and Beyond
Product Development: Nonclinical, CMC and Clinical Aspects
Pharmacovigilance: Clinical trial (Phase I-IV), Post-Marketing and QPPV Services
Compliance: GLP, GMP, GCP and QP Services
Patient Information Leaflet Testing: Over 120 Tested with 100% Positive Agency Feedback

Our clients range from virtual start-up companies to the largest multi-national corporations. Our expertise includes advanced therapy medicinal products (gene therapy products), products of recombinant DNA and hybridoma technology, nucleotide based products (RNA and DNA), synthetic peptides, chemical entities (innovative and generic), vaccines (therapeutic and prophylactic) and blood products.

Diamond Pharma Services has a network throughout Europe hence our ability to provide a local solution on the ground in a specific EU country when required. Diamond Pharma Services has also built strong relationships with other groups outside of Europe to expand the geographical expertise and services that are offered to clients of the Diamond group. Established and proven relationships are in place to offer complete solutions in the USA, Canada, Australia and New Zealand. Paul Cronin is the Director of Business Development for Diamond Pharma Services.

Paul Cronin has a BSc in Biochemistry and an MSc in international business and management. Paul previously headed business development at the Smerud Medical Research Group which is a clinical Contract Research Organisation operating in the European area with head office in Norway and subsidiary wholly owned offices throughout Europe including Austria, Denmark, Finland, Hungary, Sweden, Poland, Russia, United Kingdom. Paul started his pharmaceutical career as a regulatory affairs consultant at ERA Consulting. During his time at ERA Consulting he was involved in evolving this into a leading international regulatory consultancy and was responsible for all of its global business development activities. Paul has overall responsibility for the development, direction and implementation of Diamond Pharma’s global marketing and business development strategy. Paul Cronin can be contacted via email at pcronin@diamondpharmaservices.com or on +44(0)1279 441616.

Signed